RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Monday reported a loss of $3.8 million in its second quarter.

The Rutherford, New Jersey-based company said it had a loss of 7 cents per share. Losses, adjusted to account for discontinued operations, were 1 cent per share.

The diagnostics company posted revenue of $1.5 million in the period.

The company’s shares closed at 12 cents. A year ago, they were trading at $1.06.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX

Sign up for Daily Newsletters Manage Newsletters

Copyright © 2020 The Washington Times, LLC.